Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | Transplantation during the COVID-19 pandemic

Anna Grassi • 11 Mar 2021
EBMT 2021
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia General Leukemia Myelodysplastic Syndromes

Anna Grassi, MD, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy, outlines her experience of treating patients with hematological malignancies who require transplantation during the COVID-19 pandemic. This interview took place during the the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Related Videos

0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:44
PHOEBUS trial: oral fecal microbiotherapy for increasing OS in patients undergoing alloSCT
Florent Malard • 11 Apr 2024
2:24
Manipulating the gut microbiome to improve outcomes of alloSCT for hematological malignancies
Florent Malard • 11 Apr 2024
3:29
PTCy as GvHD prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals